Bottom line
HCXSX vs IGIB: the short answer
HCXSX (The U.S. Corporate Fixed Income Securities Portfolio) and IGIB (iShares 5-10 Year Investment Grade Corporate Bond ETF) are both mutual funds.
IGIB is cheaper at 0.04% vs 0.18% — a difference of $14 a year per $10,000 invested.
Over five years, HCXSX returned +1.1% a year vs +1.0% for IGIB (reporting dates differ).
Updated Nov 19, 2026
HCXSX vs IGIB side by side
| HCXSX | IGIB | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Hc Capital | iShares |
| Category | Corporate Bond | Corporate Bond |
| Expense ratio | 0.18% | 0.04% |
| Annual cost per $10k | $18 | $4 |
| 10-yr cost on $10k (prospectus) | $230 | $51 |
| Max front load | — | None |
| 12b-1 fee | — | — |
| 1-yr return | +2.7% | +9.6% |
| 5-yr return (annualized) | +1.1% | +1.0% |
| 10-yr return (annualized) | +2.7% | +3.4% |
| Best quarter | +8.6% | +10.3% |
| Worst quarter | −6.4% | −7.0% |
| Net assets (fund) | — | $18.2B |
| Number of holdings | — | 2,990 |
| Portfolio turnover | 7% | 27% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HCXSX | IGIB | Difference |
|---|---|---|---|
| 2024 | +2.7% | +3.7% | −0.9% |
| 2023 | +7.9% | +9.2% | −1.3% |
| 2022 | −12.9% | −14.1% | +1.2% |
| 2021 | −0.9% | −1.7% | +0.8% |
| 2020 | +10.3% | +9.6% | +0.6% |
| 2019 | +14.3% | +14.4% | −0.1% |
| 2018 | −2.3% | −0.5% | −1.8% |
| 2017 | +5.6% | +3.5% | +2.1% |
| 2016 | +6.4% | +3.4% | +3.0% |
Source: Fund prospectus bar charts
Holdings overlap
HCXSX and IGIB share none of their top holdings.
HCXSX top 10
IGIB top 10
- BlackRock Funds III — 11.07%
- Meta Platforms Inc — 0.23%
- Amazon.com Inc — 0.22%
- Anheuser-busch Co/inbev — 0.20%
- Bank Of America Corp — 0.19%
- Bank Of America Corp — 0.19%
- Bank Of America Corp — 0.19%
- Mars Inc — 0.19%
- Pfizer Investment Enter — 0.18%
- Jpmorgan Chase & Co — 0.18%
FAQ
What is the difference between HCXSX and IGIB?
Which is cheaper, HCXSX or IGIB?
Should I own both HCXSX and IGIB?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.